+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Amgen Inc. - logo

Amgen is an international biotechnology company based in California, USA. Amgen is committed to using their experience in human genetics and biologics manufacturing to create innovative treatments for life threatening diseases particularly in areas of unmet medical need where limited treatment options exist. Amgen manufactures a wide range of therapeutic products including Aranesp, Corlanor, Neulasta and Prolia.

From
From
From
Drugs for Hormonal Replacement Therapy Market Report 2025 - Product Thumbnail Image

Drugs for Hormonal Replacement Therapy Market Report 2025

  • Report
  • April 2025
  • 175 Pages
  • Global
From
Biosimilar Monoclonal Antibodies (mAbs) Market 2021-2025 - Product Thumbnail Image

Biosimilar Monoclonal Antibodies (mAbs) Market 2021-2025

  • Report
  • July 2021
  • 120 Pages
  • Global
From
US Kidney Cancer Therapeutics and Diagnostics Market to 2028 - Product Thumbnail Image

US Kidney Cancer Therapeutics and Diagnostics Market to 2028

  • Report
  • October 2023
  • 85 Pages
  • United States
From
From
Trastuzumab Biosimilars Market Report 2025 - Product Thumbnail Image

Trastuzumab Biosimilars Market Report 2025

  • Report
  • April 2025
  • 175 Pages
  • Global
From
From
Renal cell carcinoma - Pipeline Insight, 2024 - Product Thumbnail Image

Renal cell carcinoma - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Kidney Cancer Diagnostics and Therapeutics Market Report 2025 - Product Thumbnail Image

Kidney Cancer Diagnostics and Therapeutics Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Loading Indicator